NewBridge Pharmaceuticals Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
327
- Latest Deal Type
-
M&A
- (Announced)
- Investors
-
5
NewBridge Pharmaceuticals General Information
Description
Operator of a regional specialty platform intended to address the unmet medical needs and serve patients in the region. The company's platform covers the areas of pharmaceuticals and biologics that focus on cancer, diabetes, renal and cardiovascular diseases and other metabolic disorders, enabling patients to get treated when affected by any critical diseases.
Contact Information
Website
www.nbpharma.comCorporate Office
- Dubai Science Park Towers
- 17th Floor, North Tower, Al Barsha South2
- Dubai United Arab Emirates
Corporate Office
- Dubai Science Park Towers
- 17th Floor, North Tower, Al Barsha South2
- Dubai United Arab Emirates
NewBridge Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 19-Oct-2026 | Announced | Generating Revenue | |||
| 4. Equity Crowdfunding | Cancelled | Generating Revenue | ||||
| 3. Later Stage VC (Series C) | 29-May-2019 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 20-Sep-2010 | $12M | $16M | Completed | Generating Revenue | |
| 1. Early Stage VC | $4M | $4M | Completed | Startup |
NewBridge Pharmaceuticals Comparisons
Industry
Financing
Details
NewBridge Pharmaceuticals Competitors (20)
One of NewBridge Pharmaceuticals’s 20 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| The Zambon Group | Private Debt Financed | Bresso, Italy |
NewBridge Pharmaceuticals Signals
NewBridge Pharmaceuticals Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Elan (Pharmaceuticals) | Corporation | Minority | ||
| Revelation Partners | Venture Capital | Minority | ||
| Burrill & Co | Merchant Banking Firm | Minority | ||
| Kuwait Life Sciences Company | Venture Capital | Minority | ||
| Kuwait Investment Authority | Sovereign Wealth Fund | Minority |
NewBridge Pharmaceuticals FAQs
-
When was NewBridge Pharmaceuticals founded?
NewBridge Pharmaceuticals was founded in 2010.
-
Where is NewBridge Pharmaceuticals headquartered?
NewBridge Pharmaceuticals is headquartered in Dubai, United Arab Emirates.
-
What is the size of NewBridge Pharmaceuticals?
NewBridge Pharmaceuticals has 327 total employees.
-
What industry is NewBridge Pharmaceuticals in?
NewBridge Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is NewBridge Pharmaceuticals a private or public company?
NewBridge Pharmaceuticals is a Private company.
-
What is NewBridge Pharmaceuticals’s current revenue?
The current revenue for NewBridge Pharmaceuticals is .
-
How much funding has NewBridge Pharmaceuticals raised over time?
NewBridge Pharmaceuticals has raised $64M.
-
Who are NewBridge Pharmaceuticals’s investors?
Elan (Pharmaceuticals), Revelation Partners, Burrill & Co, Kuwait Life Sciences Company, and Kuwait Investment Authority have invested in NewBridge Pharmaceuticals.
-
Who are NewBridge Pharmaceuticals’s competitors?
Genentech, Pfizer (Vienna), Merck & Co., Ability Pharma, and The Zambon Group are some of the 20 competitors of NewBridge Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process